Neuropsychological impairment detected by the Montreal Cognitive Assessment monitors recovery and predicts treatment dropout in substance use disorders
BJPsych Open · 2026-03 · 12 (2)
DOI: 10.1192/bjo.2026.10986 ↗Kurz gefasst
Fachartikel in der Zeitschrift BJPsych Open, online erschienen am 05.03.2026. Verfasst von Nerea Requena-Ocaña und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychobiology and Methodology of Behavioural Sciences, https://ror.org/036b2ww28University of Malaga, Málaga, Spain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Substance use disorder (SUD) is frequently associated with cognitive impairment that negatively affects treatment adherence and clinical outcomes. Neuropsychological assessments provide detailed information but are often impractical in clinical settings, underscoring the value of brief but sensitive tools such as the Montreal Cognitive Assessment (MoCA).
Aims
This study aimed to evaluate the utility of MoCA in detecting cognitive impairment in SUD, examining cognitive recovery following sustained abstinence, exploring gender differences in cognitive progression and determining whether baseline cognitive performance predicts treatment dropout.
Method
Ninety-five SUD patients and 57 healthy controls completed MoCA at baseline and were reassessed after 6 months.
Results
At baseline, 72.60% of individuals demonstrated cognitive impairment compared with controls, with deficits evident in both global cognition and visuospatial/executive, attention, memory and language domains. Following 6 months of abstinence, deterioration rates decreased to 50%, indicating substantial but not complete recovery, because the improvement in overall cognition was moderate. Male patients showed significantly greater cognitive gains than female patients, particularly in visuospatial/executive and digit span performance. Patients impaired at baseline reported more severe alcohol use and earlier onset of cannabis use disorder. Patients with cocaine use disorder showed the poorest recovery and the highest rate of treatment dropout. Lower baseline language and fluency scores were strongly associated with treatment discontinuation. Language deficits, together with cocaine use disorder, predicted 69% of dropout cases.
Conclusions
Findings indicate MoCA as a practical screening tool for early detection of cognitive impairment, longitudinal monitoring and personalised treatment planning in SUD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychobiology and Methodology of Behavioural Sciences, https://ror.org/036b2ww28University of Malaga, Málaga, Spain.
- Area of Educational Psychology and Psychobiology International, International University of La Rioja, La Rioja, Spain.
- Department of Biological and Health Psychology, Autonomous University of Madrid, Madrid, Spain.
ORCID-Profile: Nerea Requena-Ocaña
Zitieren
APA
Requena-Ocaña, N., Mañas-Padilla, M. C., Sánchez-Álvarez, N., Sampedro-Piquero, P., & Castilla-Ortega, E. (2026). Neuropsychological impairment detected by the Montreal Cognitive Assessment monitors recovery and predicts treatment dropout in substance use disorders. BJPsych Open, 12(2). https://doi.org/10.1192/bjo.2026.10986
Vancouver
Requena-Ocaña N, Mañas-Padilla MC, Sánchez-Álvarez N, Sampedro-Piquero P, Castilla-Ortega E. Neuropsychological impairment detected by the Montreal Cognitive Assessment monitors recovery and predicts treatment dropout in substance use disorders. BJPsych Open. 2026;12(2). doi:10.1192/bjo.2026.10986
BibTeX
@article{RequenaOcaa2026,
author = {Requena-Ocaña, Nerea and Mañas-Padilla, M Carmen and Sánchez-Álvarez, Nicolás and Sampedro-Piquero, Patricia and Castilla-Ortega, Estela},
title = {Neuropsychological impairment detected by the Montreal Cognitive Assessment monitors recovery and predicts treatment dropout in substance use disorders},
journal = {BJPsych Open},
year = {2026},
volume = {12},
number = {2},
doi = {10.1192/bjo.2026.10986}
}
EUVIMED